J Hayes1, A Richardson, C Frampton. 1. Department of Applied Science and Allied Health, Christchurch Polytechnic Institute of Technology, Christchurch, New Zealand.
Abstract
BACKGROUND: Breast cancer is the most commonly diagnosed invasive cancer in New Zealand women and modifiable lifestyle risk factors may contribute to this. AIM: To estimate population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand. METHODS: Estimates of the magnitude of the impact of modifiable lifestyle risk factors for breast cancer (relative risks and odds ratios obtained from published epidemiological studies) and the prevalence of exposure in New Zealand were used to calculate the population attributable risk percent (PAR%) for each risk factor. The PAR% show the relative importance of these considered risk factors and give an indication of the potential impact of reducing the prevalence of these lifestyle risk factors on the incidence of breast cancer in New Zealand. RESULTS: Six modifiable lifestyle factors were identified for breast cancer. These were obesity, lack of physical activity, high alcohol intake, oral contraceptive use, hormone replacement therapy (HRT) and delayed first birth. The PAR% for these risk factors ranged from 1% for delayed first birth to 10% for obesity (16% for Maori women and 17% for Pacific women). CONCLUSIONS: The most important primary preventive strategies to reduce the risk of breast cancer in New Zealand are lifestyle changes to reduce obesity, promoting regular physical activity (which may in turn reduce the prevalence of obesity), reducing HRT use and avoiding high alcohol intake. Strategies that encourage regular physical activity and reduce obesity could also have other benefits, such as reduced risks of cardiovascular disease and diabetes.
BACKGROUND:Breast cancer is the most commonly diagnosed invasive cancer in New Zealand women and modifiable lifestyle risk factors may contribute to this. AIM: To estimate population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand. METHODS: Estimates of the magnitude of the impact of modifiable lifestyle risk factors for breast cancer (relative risks and odds ratios obtained from published epidemiological studies) and the prevalence of exposure in New Zealand were used to calculate the population attributable risk percent (PAR%) for each risk factor. The PAR% show the relative importance of these considered risk factors and give an indication of the potential impact of reducing the prevalence of these lifestyle risk factors on the incidence of breast cancer in New Zealand. RESULTS: Six modifiable lifestyle factors were identified for breast cancer. These were obesity, lack of physical activity, high alcohol intake, oral contraceptive use, hormone replacement therapy (HRT) and delayed first birth. The PAR% for these risk factors ranged from 1% for delayed first birth to 10% for obesity (16% for Maori women and 17% for Pacific women). CONCLUSIONS: The most important primary preventive strategies to reduce the risk of breast cancer in New Zealand are lifestyle changes to reduce obesity, promoting regular physical activity (which may in turn reduce the prevalence of obesity), reducing HRT use and avoiding high alcohol intake. Strategies that encourage regular physical activity and reduce obesity could also have other benefits, such as reduced risks of cardiovascular disease and diabetes.
Authors: Rulla M Tamimi; Donna Spiegelman; Stephanie A Smith-Warner; Molin Wang; Mathew Pazaris; Walter C Willett; A Heather Eliassen; David J Hunter Journal: Am J Epidemiol Date: 2016-12-06 Impact factor: 4.897
Authors: Catherine M Olsen; Louise F Wilson; Christina M Nagle; Bradley J Kendall; Christopher J Bain; Nirmala Pandeya; Penelope M Webb; David C Whiteman Journal: Aust N Z J Public Health Date: 2015-10 Impact factor: 2.939
Authors: Joo Eun Lee; Sang Ah Lee; Tae Hyun Kim; Sohee Park; Yoon Soo Choy; Yeong Jun Ju; Eun-Cheol Park Journal: Cancer Res Treat Date: 2018-01-22 Impact factor: 4.679
Authors: Natalie J Engmann; Marzieh K Golmakani; Diana L Miglioretti; Brian L Sprague; Karla Kerlikowske Journal: JAMA Oncol Date: 2017-09-01 Impact factor: 31.777
Authors: Leandro Fórnias Machado de Rezende; Leandro Martin Totaro Garcia; Grégore Iven Mielke; Dong Hoon Lee; Kana Wu; Edward Giovannucci; José Eluf-Neto Journal: Cancer Epidemiol Date: 2018-07-19 Impact factor: 2.984